Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Grégoire

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Cell Adhesion & Migration|February 25, 2010
What's the place of immunotherapy in malignant mesothelioma treatments?Marc Grégoire
Bulletin Du Cancer|January 24, 2007
[Immunotherapy and malignant mesothelioma: clinical perspectives]Marc Grégoire, Frédéric Ebstein
Immunotherapy|June 4, 2013
Requirement of tumor-associated antigen-specific CD4+ T cells for an efficient dendritic cell vaccine in antitumor immunotherapyThomas Simon, Jean-François Fonteneau, Marc Grégoire
Immunotherapy|July 20, 2010
Dendritic cell preparation for immunotherapeutic interventionsThomas Simon, Jean-François Fonteneau, Marc Grégoire
Future Oncology (London, England)|August 5, 2017
Viral cancer therapies: are they ready for combination with other immunotherapies?Nicolas Boisgerault, Marc Grégoire, Jean-François Fonteneau
Biomed Research International|March 20, 2013
MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challengeDavid Roulois, Marc Grégoire, Jean-François Fonteneau
Bulletin Du Cancer|February 29, 2008
[New diagnostic markers for malignant pleural mesothelioma]Bogdan-Dragos Grigoriu, Marc Grégoire, Bachar Chahine, et al.
Cytotherapy|June 13, 2012
Purification of circulating plasmacytoid dendritic cells using counterflow centrifugal elutriation and immunomagnetic beadsDelphine Coulais, Clarisse Panterne, Jean-François Fonteneau, et al.
Oncoimmunology|June 14, 2013
Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cellsJean-François Fonteneau, Jean-Baptiste Guillerme, Frédéric Tangy, et al.
Physics in Medicine and Biology|August 8, 2014
Evaluation of bias voltage modulation sequence for nonlinear contrast agent imaging using a capacitive micromachined ultrasonic transducer arrayAnthony Novell, Mathieu Legros, Jean-Marc Grégoire, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Cell Adhesion & Migration|February 25, 2010
What's the place of immunotherapy in malignant mesothelioma treatments?Marc Grégoire
Bulletin Du Cancer|January 24, 2007
[Immunotherapy and malignant mesothelioma: clinical perspectives]Marc Grégoire, Frédéric Ebstein
Immunotherapy|June 4, 2013
Requirement of tumor-associated antigen-specific CD4+ T cells for an efficient dendritic cell vaccine in antitumor immunotherapyThomas Simon, Jean-François Fonteneau, Marc Grégoire
Immunotherapy|July 20, 2010
Dendritic cell preparation for immunotherapeutic interventionsThomas Simon, Jean-François Fonteneau, Marc Grégoire
Future Oncology (London, England)|August 5, 2017
Viral cancer therapies: are they ready for combination with other immunotherapies?Nicolas Boisgerault, Marc Grégoire, Jean-François Fonteneau
Biomed Research International|March 20, 2013
MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challengeDavid Roulois, Marc Grégoire, Jean-François Fonteneau
Bulletin Du Cancer|February 29, 2008
[New diagnostic markers for malignant pleural mesothelioma]Bogdan-Dragos Grigoriu, Marc Grégoire, Bachar Chahine, et al.
Cytotherapy|June 13, 2012
Purification of circulating plasmacytoid dendritic cells using counterflow centrifugal elutriation and immunomagnetic beadsDelphine Coulais, Clarisse Panterne, Jean-François Fonteneau, et al.
Oncoimmunology|June 14, 2013
Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cellsJean-François Fonteneau, Jean-Baptiste Guillerme, Frédéric Tangy, et al.
Physics in Medicine and Biology|August 8, 2014
Evaluation of bias voltage modulation sequence for nonlinear contrast agent imaging using a capacitive micromachined ultrasonic transducer arrayAnthony Novell, Mathieu Legros, Jean-Marc Grégoire, et al.
Pageof 7